![Does a B from USPSTF Guarantee Coverage? Lung Screening will Define Medicare Stance](https://cdn.cancerletter.com/media/2024/01/07061407/40-12-lung.jpg)
![Does a B from USPSTF Guarantee Coverage? Lung Screening will Define Medicare Stance](https://cdn.cancerletter.com/media/2024/01/07061407/40-12-lung.jpg)
Cover Story
The Centers for Medicare and Medicaid Services is facing the formidable challenge of deciding what kinds of patients should be screened for lung cancer.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Trending Stories
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Tracking Trump’s early impact on cancer policy
Research and care disrupted, NCI programs face unpredictable future - Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Foundations acquire a critical new role as federal funding for cancer research falters
- Our challenge: To find zen in chaos